You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Androgen Ablation

Showing 1 - 25 of 3,882
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone, Sunitinib)

Active, not recruiting
  • Prostate Cancer
  • Abiraterone Acetate
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 6, 2022

Adenocarcinoma of the Prostate Trial in Washington, Baltimore, Bethesda (Radiation Therapy, Androgen Deprivation Therapy (ADT))

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • Radiation Therapy
  • Androgen Deprivation Therapy (ADT)
  • Washington, District of Columbia
  • +2 more
Oct 25, 2022

Prostate Cancer Trial in Houston (Cabozantinib, Androgen Ablation Therapy)

Completed
Has Results
  • Prostate Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 23, 2022

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Houston (Abiraterone Acetate, Bicalutamide, Degarelix)

Active, not recruiting
  • Prostate Adenocarcinoma
  • Recurrent Prostate Carcinoma
  • Abiraterone Acetate
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Prostate Cancer Trial in Cincinnati (Apalutamide Oral Product, Androgen Deprivation Therapy (ADT), Focal Therapy)

Not yet recruiting
  • Prostate Cancer
  • Apalutamide Oral Product
  • +2 more
  • Cincinnati, Ohio
    University of Cincinnati Medical Center
Mar 27, 2023

Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Houston (drug, procedure,

Recruiting
  • Prostate Carcinoma
  • +6 more
  • Abiraterone Acetate
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 10, 2022

Cognitive Functioning and Functional Status in Prostate Cancer

Active, not recruiting
  • Prostate Cancer
  • Questionaires
  • fMRI scan (optional)
  • Duarte, California
  • +1 more
Mar 18, 2022

Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Scottsdale, Rochester

Active, not recruiting
  • Prostate Adenocarcinoma
  • +5 more
  • Androgen Suppression
  • +3 more
  • Scottsdale, Arizona
  • +1 more
Jan 5, 2023

Cancer of Prostate, Cancer of the Prostate, Tumors, Prostate Trial in Pittsburgh (androgen ablation (AA), DC1 vaccine)

Completed
Has Results
  • Cancer of Prostate
  • +6 more
  • androgen ablation (AA)
  • DC1 vaccine
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Cancer institute
Oct 13, 2020

Metastatic Hormone-sensitive Prostate Cancer Trial in United States (androgen-deprivation therapy, docetaxel)

Active, not recruiting
Has Results
  • Metastatic Hormone-sensitive Prostate Cancer
  • Anchorage, Alaska
  • +342 more
Jan 29, 2023

Prostate Cancer Trial in Madison (Zometa, zometa)

Completed
Has Results
  • Prostate Cancer
  • Madison, Wisconsin
    University of Wisconsin
Nov 15, 2019

Localized Prostate Carcinoma, Castration-Naive Prostate Cancer, Intermediate Risk Prostate Cancer Trial in Turku (Degarelix,

Not yet recruiting
  • Localized Prostate Carcinoma
  • +3 more
  • Degarelix
  • MRI-guided transurethral ultrasound ablation (TULSA)
  • Turku, Southwest Finland, Finland
    Turku University Hospital
Jun 14, 2023

Castration-resistant Prostate Cancer, Homologous Recombination Deficiency Trial in Sydney (Testosterone Enanthate 100 MG/ML

Recruiting
  • Castration-resistant Prostate Cancer
  • Homologous Recombination Deficiency
  • Testosterone Enanthate 100 MG/ML Injectable Solution
  • Testosterone Enanthate 100 MG/ML Injectable Solution / Carboplatin AUC 5
  • Sydney, New South Wales, Australia
    Kinghorn Cancer Centre, St. Vincent's Hospital
Dec 16, 2022

Prostate Cancer Trial in Boston (Flutamide (Eulexin) and Lupron or Zoladex, External Beam Radiotherapy)

Completed
  • Prostate Cancer
  • Flutamide (Eulexin) and Lupron or Zoladex
  • External Beam Radiotherapy
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Dec 16, 2021

Prostate Cancer Trial in United States (NanoTherm Ablation)

Recruiting
  • Prostate Cancer
  • NanoTherm Ablation
  • Tampa, Florida
  • +3 more
Mar 4, 2022

Adenocarcinoma of the Prostate Trial in United States (Muscadine Plus, Placebos)

Terminated
  • Adenocarcinoma of the Prostate
  • Muscadine Plus
  • Placebos
  • Duarte, California
  • +12 more
Dec 6, 2022

Prostate Cancer Trial in Milwaukee (Standard of care ADT + (HMB + arginine + glutamine), Standard of care ADT)

Unknown status
  • Prostate Cancer
  • Standard of care ADT + (HMB + arginine + glutamine)
  • Standard of care ADT
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
Jul 24, 2019

Polycystic Ovary Syndrome, Infertility, Female Trial in Oklahoma City (AblaCare System)

Recruiting
  • Polycystic Ovary Syndrome
  • Infertility, Female
  • AblaCare System
  • Oklahoma City, Oklahoma
    University of Oklahoma
Jul 5, 2022

Stage IV Prostate Cancer Trial in Baltimore (procedure, drug, other, biological)

Completed
Has Results
  • Stage IV Prostate Cancer
  • Cryosurgery
  • +3 more
  • Baltimore, Maryland
    Johns Hopkins University/Sidney Kimmel Cancer Center
Nov 11, 2021

Prostate Cancer, Androgen Deprivation Therapy Trial (HIFU hemi-ablation combined with ADT.)

Unknown status
  • Prostate Cancer
  • Androgen Deprivation Therapy
  • HIFU hemi-ablation combined with ADT.
  • (no location specified)
Sep 25, 2019

Prostate Cancer Trial (ADT, Enzalutamide, Talazoparib)

Not yet recruiting
  • Prostate Cancer
  • (no location specified)
May 15, 2023

Prostate Cancer Trial in Australia, New Zealand (Adjuvant Radiotherapy, Early Salvage Radiotherapy)

Active, not recruiting
  • Prostate Cancer
  • Adjuvant Radiotherapy
  • Early Salvage Radiotherapy
  • Campbelltown, New South Wales, Australia
  • +35 more
Nov 16, 2022

Prostatic Tumors Trial in Toronto (Pre-treatment tumour oxygen measurements)

Active, not recruiting
  • Prostatic Neoplasms
  • Pre-treatment tumour oxygen measurements
  • Toronto, Ontario, Canada
    Princess Margaret Hospital
Oct 4, 2021

Prostate Cancer Trial in Boston (Docetaxel, Androgen Hormonal Suppression and Radiation, Androgen Suppression Therapy and

Completed
Has Results
  • Prostate Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute and (Sanofi-Aventis Consortium)
Jan 6, 2022

Prostate Cancer Trial in Jacksonville (< 15% risk of + LN, > 15% risk of + LN)

Active, not recruiting
Has Results
  • Prostate Cancer
  • < 15% risk of + LN
  • > 15% risk of + LN
  • Jacksonville, Florida
    University of Florida Proton Therapy Institute
Dec 1, 2021